Genmab — December 2024
-
Knock-Your-Socks-Off-News – December 2024 https://www.linkedin.com/pulse/knock-your-socks-off-news-december-2024-genmab-zosre/
-
Genmab får skåret kursmålet til 1700 kr. fra 2050 kr. af JP Morgan https://proinvestor.com/investornyt/1249692/genmab-far-skaret-kursmalet-til-1700-kr-fra-2050-kr-af-jp-morgan
-
Novo Nordisk to present new data from sickle cell disease and haemophilia trials at the 66th American Society of Hematology (ASH) annual meeting / Mim8 https://www.globenewswire.com/news-release/2024/12/03/2990557/0/en/Novo-Nordisk-to-present-new-data-from-sickle-cell-disease-and-haemophilia-trials-at-the-66th-American-Society-of-Hematology-ASH-annual-meeting.html
-
the GEN1042 trial in combination with radiotherapy / pembrolizumab set to Active, not recruiting - curious if we can get some info on that soonish https://clinicaltrials.gov/study/NCT05491317
-
Scancell Announces Genmab Exercises Option to a Second Commercial License Agreement https://www.investegate.co.uk/announcement/rns/scancell-holdings--sclp/second-commercial-license-agreement-with-genmab-/8588688
-
‘As bispecific antibodies change DLBCL treatment paradigm, Epkinly draws attention’
https://www.koreabiomed.com/news/articleView.html?idxno=25928 -
Genmab expands its pipeline with $630m Scancell deal https://pharmaphorum.com/news/genmab-expands-its-pipeline-630m-scancell-deal
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind